Lexpos News

/Lexpos News

MHRA: Drug Safety Update: October 2024

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 3 October 2024) has been published and includes articles on: GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse. Insulin pumps and continuous glucose monitoring (CGM) equipment: guidance for users on [...]

The post MHRA: Drug Safety Update: October 2024 appeared first on Community Pharmacy England.

By |October 24th, 2024|Lexpos News|Comments Off on MHRA: Drug Safety Update: October 2024

Clarification regarding retained margin in 2023/24

Minister Stephen Kinnock recently responded to a Parliamentary Question regarding pharmacy reimbursement. In his response, he stated that pharmacies were allowed to retain £850m medicine margin in the year 2023/24. The pharmacy funding settlement for 2022/23 and 2023/24 included an uplift to the Drug Tariff, as £100m in excess margin earned by the sector in [...]

The post Clarification regarding retained margin in 2023/24 appeared first on Community Pharmacy England.

By |October 24th, 2024|Lexpos News|Comments Off on Clarification regarding retained margin in 2023/24

2024 mandatory workforce survey is now open

NHS England’s 2024 Community Pharmacy Workforce Survey is now open. Completion of the survey is a mandatory requirement for all pharmacy owners. The survey opened on 16th October and will close at midnight on 11th December 2024. How to complete the survey The 2024 survey maintains a consistent approach to the 2023 and previous surveys, focusing [...]

The post 2024 mandatory workforce survey is now open appeared first on Community Pharmacy England.

By |October 23rd, 2024|Lexpos News, Workforce, Workforce survey|Comments Off on 2024 mandatory workforce survey is now open

MHRA Class 2 Medicines Recall: Phenobarbital Bristol Labs 15mg Tablets (Bristol Laboratories Ltd)

Drug alert number: EL (24)A/50 Date issued: 23 October 2024 Bristol Laboratories Ltd. are recalling one batch of Phenobarbital Bristol Labs 15mg Tablets as a precautionary measure due to the potential of contamination of small metallic particles within the tablets. PL 17907/0175 DMRC Number: DMRC-32910584 SNOMED Code:21039211000001106 Batch No Expiry Date Pack Size First Distributed [...]

The post MHRA Class 2 Medicines Recall: Phenobarbital Bristol Labs 15mg Tablets (Bristol Laboratories Ltd) appeared first on Community Pharmacy England.

By |October 23rd, 2024|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Phenobarbital Bristol Labs 15mg Tablets (Bristol Laboratories Ltd)

Secretary of State launches national conversation on health service

The Secretary of State for Health and Social Care has this week launched a national conversation on the NHS, seeking input and ideas to shape the future of a reformed health service. Patients, members of the public and anyone working in the NHS have been invited to submit their views and ideas via the change.nhs.uk portal. [...]

The post Secretary of State launches national conversation on health service appeared first on Community Pharmacy England.

By |October 22nd, 2024|Lexpos News|Comments Off on Secretary of State launches national conversation on health service